Five9 announces resignation of director David Welsh; appoints Sudhakar Ramakrishna

Five9, Inc.

David Welsh resigned as Class II director, Lead Independent Director, and chair of Nominating & Governance Committee effective Sept 26, 2025; no disagreement with company.
Robert Zollars appointed Lead Independent Director; Jonathan Mariner chair of Nominating & Governance; Michael Burdiek chair of Compensation Committee.
Sudhakar Ramakrishna appointed as Class II director and to Nominating & Governance Committee; he is CEO of SolarWinds and also on Cardinal Health board.
Ramakrishna receives $400k RSU vesting over 3 years and $133,333 RSU vesting on first anniversary; initial equity grants per non-employee director policy.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.